Literature DB >> 381094

Clinical features and natural history of Crohn's disease.

H S Mekhjian, D M Switz, C S Melnyk, G B Rankin, R K Brooks.   

Abstract

Records of 1084 patients entered into the National Cooperative Crohn's Disease Study were analyzed to gather information concerning the natural history and clinical features of Crohn's disease. The age of onset reached a single peak between the second and fourth decade and was evenly distributed in both sexes. There was an average interval of 35 mo from onset of symptoms to diagnosis. Involvement of both colon and terminal ileum was the most frequent pattern and was present in 55% of patients. The disease was confined to the terminal ileum, other areas of the small intestine, or colon-only in 14%, 3%, and 15% of patients, respectively. Sigmoidoscopic abnormalities were seen in 34% of all patients and 51% of patients with Crohn's colitis. Diarrhea, abdominal pain, weight loss, and fever were present in the majority of the patients. Lower GI bleeding, fever, and perianal complications characterized patients with colon-only involvement. The frequency of extra intestinal manifestations was similar in all groups. Among patients who were randomized to placebo, 32% achieved a spontaneous remission by the end of 17 wk, and 53% of these were still in remission at the end of 24 mo. Clinical remission was associated with an improvement in barium x-rays in 18% of the patients. The predicted factors associated with favorable outcome in placebo-treated patients were: previous surgical removal of all observable disease, absence of perianal disease, and Crohn's Disease Activity Index value under 200.

Entities:  

Mesh:

Year:  1979        PMID: 381094

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  97 in total

1.  Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?

Authors:  Maria Elena Riccioni; Riccardo Urgesi; Rossella Cianci; Alessandra Bizzotto; Cristiano Spada; Guido Costamagna
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

Review 2.  Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives.

Authors:  Maki Nakahigashi; Takayuki Yamamoto; Rodolfo Sacco; Hiroyuki Hanai; Fumio Kobayashi
Journal:  Int J Colorectal Dis       Date:  2015-08-15       Impact factor: 2.571

3.  Colonoscopic study of 50 patients with colonic tuberculosis.

Authors:  S Shah; V Thomas; M Mathan; A Chacko; G Chandy; B S Ramakrishna; D D Rolston
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

4.  Granulomatous tonsillitis. A rare extraintestinal manifestation of Crohn's disease.

Authors:  T Bozkurt; M Langer; K Fendel; G Lux
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

5.  Small bowel infarction mimicking Crohn's ileitis.

Authors:  P J Thuluvath; M D Feher; J Wiggins
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

6.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

7.  Compromised neuroimmune status in rats with experimental colitis.

Authors:  Lysa Boissé; Marja D Van Sickle; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

8.  Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease.

Authors:  J P Van de Merwe; P I Schmitz; F Wensinck
Journal:  J Hyg (Lond)       Date:  1981-08

9.  Capsule endoscopy in suspected small bowel Crohn's disease: economic impact of disease diagnosis and treatment.

Authors:  Jonathan A Leighton; Ian M Gralnek; Randel E Richner; Michael J Lacey; Frank J Papatheofanis
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

10.  Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.

Authors:  D G Forcione; M J Rosen; J B Kisiel; B E Sands
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.